-
公开(公告)号:US4375478A
公开(公告)日:1983-03-01
申请号:US354117
申请日:1982-03-02
申请人: Bruce W. Horrom , Herman H. Stein
发明人: Bruce W. Horrom , Herman H. Stein
IPC分类号: A61K31/195 , C07C101/60
CPC分类号: C07C229/60
摘要: Described are compounds of the formula ##STR1## wherein Y and Z independently of one another denote hydrogen, halo or trihalomethyl, with the proviso that Y and Z cannot both be hydrogen, R is hydrogen or loweralkyl, n is 5 to 19, and pharmaceutically acceptable salts thereof.The compounds are active hypocholesterolemic agents.
摘要翻译: 描述的是下式的化合物,其中Y和Z彼此独立地表示氢,卤素或三卤代甲基,条件是Y和Z不能同时为氢,R为氢或低级烷基,n为5至19, 其可接受的盐。 这些化合物是活性降胆固醇药。
-
公开(公告)号:US4927807A
公开(公告)日:1990-05-22
申请号:US240567
申请日:1988-09-08
IPC分类号: A61K31/16 , A61K31/21 , A61K31/215 , A61K31/255 , A61K31/265 , A61K31/42 , A61K31/421 , A61K31/495 , A61K31/496 , A61K31/535 , A61K31/5375 , A61K31/5377 , A61K38/55 , A61P27/02 , A61P27/06 , A61P43/00 , C07C233/16 , C07C235/08 , C07C237/08 , C07C271/22 , C07C271/34 , C07C305/04 , C07C307/06 , C07C309/64 , C07C317/28 , C07C317/44 , C07C323/52 , C07C323/60 , C07C323/64 , C07D211/44 , C07D211/46 , C07D211/74 , C07D233/64 , C07D263/22 , C07D263/24 , C07D295/20 , C07D405/12 , C07D413/06
CPC分类号: A61K38/553 , Y10S514/913 , Y10S530/86
摘要: A method and a composition for treating or reducing and/or controlling intraocular pressure comprising administering an effective amount of a renin inhibiting compound of the formula: ##STR1## wherein A is a substituent; W is CO or CHOH and U is CH.sub.2 or NR.sub.2 wherein R.sub.2 is hydrogen or loweralkyl; with the proviso that when W is CHOH then U is CH.sub.2 ; R.sub.1 is loweralkyl, cycloalkyl, benzyl, (alpha, alpha)-dimethylbenzyl, 4-hydroxybenzyl, 4-methoxybenzyl, halobenzyl, (1-naphthyl)methyl, (2-naphthyl)methyl, (4-imidazoyl)methyl, phenethyl, 1-benzyloxyethyl, phenoxy, thiophenoxy or anilino; R.sub.3 is loweralkyl, loweralkenyl, ((alkoxy)alkoxy)alkyl, carboxyalkyl, (thioalkoxy)alkyl, benzyl or heterocyclic ring substituted methyl; and R.sub.4 is a substituted amino group; or pharmaceutically acceptable salts or esters thereof.Also disclosed are compositions, methods and kits for treating glaucoma or reducing and/or controlling intraocular pressure wherein the renin inhibiting compound is administered in combination with a beta-adrenergic antagonist, a steroidal antiinflammatory agent or an angiotensin converting enzyme inhibiting compound.
-
公开(公告)号:US5631401A
公开(公告)日:1997-05-20
申请号:US378334
申请日:1995-01-24
申请人: Herman H. Stein , William R. Baker , Anthony K. L. Fung , Saul H. Rosenberg , Todd W. Rockway , Stephen A. Fakhoury , David S. Garvey , B. Gregory Donner , William J. McClellan , Stephen J. O'Connor , Rajnandan Prasad , Wang Shen , Gerard M. Sullivan
发明人: Herman H. Stein , William R. Baker , Anthony K. L. Fung , Saul H. Rosenberg , Todd W. Rockway , Stephen A. Fakhoury , David S. Garvey , B. Gregory Donner , William J. McClellan , Stephen J. O'Connor , Rajnandan Prasad , Wang Shen , Gerard M. Sullivan
IPC分类号: C07C233/58 , C07C233/59 , C07C233/60 , C07C233/62 , C07C233/63 , C07C323/40 , C07D211/16 , C07D211/70 , C07D217/06 , C07D277/34 , C07D295/135 , C07D307/52 , C07D307/58 , C07D307/91 , C07D317/64 , C07D333/20 , C07D333/32 , C07C229/46 , A61K31/19 , A61K31/195
CPC分类号: C07C233/58 , C07C233/59 , C07C233/60 , C07C233/62 , C07C233/63 , C07C323/40 , C07D211/16 , C07D211/70 , C07D217/06 , C07D277/34 , C07D295/135 , C07D307/52 , C07D307/58 , C07D307/91 , C07D317/64 , C07D333/20 , C07D333/32 , C07C2101/02 , C07C2101/04 , C07C2101/08 , C07C2101/14
摘要: The present invention provides a compound of the formula ##STR1## or a pharmaceutically acceptable salt thereof, which are useful in inhibiting protein farnesyltransferase and the farnesylation of the oncogene protein Ras or inhibiting de novo squalene production resulting in the inhibition of cholesterol biosynthesis, processes for the preparation of the compounds of the invention in addition to intermediates useful in these processes, a pharmaceutical composition, and to methods of using such compounds.
摘要翻译: 本发明提供式IMA的化合物或其药学上可接受的盐,其可用于抑制蛋白法呢基转移酶和癌基因蛋白Ras的法呢基化或抑制从头角鲨烯生产导致胆固醇生物合成的抑制, 除了可用于这些方法的中间体之外,本发明化合物的制备,药物组合物以及使用这些化合物的方法。
-
公开(公告)号:US5389647A
公开(公告)日:1995-02-14
申请号:US71747
申请日:1993-06-09
申请人: William R. Baker , Steven A. Boyd , Anthony K. L. Fung , Herman H. Stein , Jon F. Denissen , Charles W. Hutchins
发明人: William R. Baker , Steven A. Boyd , Anthony K. L. Fung , Herman H. Stein , Jon F. Denissen , Charles W. Hutchins
IPC分类号: A61K31/495 , A61K31/535 , A61K38/55 , C07D211/46 , C07D401/12 , C07D405/12 , C07D413/12 , C07D451/06 , C07D451/14 , A61K31/445 , C07D401/08 , C07D413/08
CPC分类号: C07D451/06 , A61K31/495 , A61K31/535 , A61K38/553 , C07D211/46 , C07D401/12 , C07D405/12 , C07D413/10 , C07D451/14
摘要: A renin inhibiting compound of the formula: ##STR1## wherein X is O, NH or S and G is a mimic of the Leu-Val cleavage site of angiotensinogen; or a pharmaceutically acceptable salt, ester or prodrug thereof; with the proviso that the compound is not N-(3-(4-Morpholino)propyl)-5(S)-(2(S)-(1(S)-(4-methoxymethoxy)piperidin-1-yl)carbonyl-2-phenyl)ethoxyhexanamido)-6-cyclohexyl-4(S)-hydroxy-2(S)-isopropylhexanamide.
摘要翻译: 下式的肾素抑制化合物:其中X是O,NH或S,G是血管紧张素原的Leu-Val切割位点的模拟物; 或其药学上可接受的盐,酯或前药; 条件是该化合物不是N-(3-(4-吗啉代)丙基)-5(S) - (2(S) - (1(S) - (4-甲氧基甲氧基)哌啶-1-基) 羰基-2-苯基)乙氧基己酰氨基)-6-环己基-4(S) - 羟基-2(S) - 异丙基己酰胺。
-
5.
公开(公告)号:US5831115A
公开(公告)日:1998-11-03
申请号:US626859
申请日:1996-04-11
申请人: David L Arendsen , William R. Baker , Stephen A Fakhoury , Anthony K. L. Fung , David S. Garvey , William J. McClellan , Stephen J. O'Connor , Rajnandan N. Prasad , Todd W. Rockway , Saul H. Rosenberg , Herman H. Stein , Wang Shen , David M. Stout , Gerard M. Sullivan , David J. Augeri
发明人: David L Arendsen , William R. Baker , Stephen A Fakhoury , Anthony K. L. Fung , David S. Garvey , William J. McClellan , Stephen J. O'Connor , Rajnandan N. Prasad , Todd W. Rockway , Saul H. Rosenberg , Herman H. Stein , Wang Shen , David M. Stout , Gerard M. Sullivan , David J. Augeri
IPC分类号: A61K31/195 , A61K31/215 , A61K31/38 , A61K31/381 , A61K31/41 , A61K31/4245 , A61K31/433 , A61P3/06 , A61P9/00 , A61P9/08 , A61P31/04 , A61P35/00 , A61P43/00 , C07C233/58 , C07C233/59 , C07C233/60 , C07C235/40 , C07C235/82 , C07D271/06 , C07D271/10 , C07D285/10 , C07D333/20 , C07C229/00 , A01N37/10
CPC分类号: C07C235/82 , C07C233/58 , C07C233/59 , C07C233/60 , C07C235/40 , C07D333/20 , C07C2101/04
摘要: The present invention provides a compound of the formula ##STR1## or a pharmaceutically acceptable salt thereof, which are useful for inhibiting protein farnesyltransferase and the farnesylation of the oncogene protein Ras or inhibiting de novo squalene production resulting in the inhibition of cholesterol biosynthesis, processes for the preparation of the compounds of the invention in addition to intermediates useful in these processes, a pharmaceutical composition, and to methods of using such compounds.
摘要翻译: 本发明提供了一种式IMA化合物或其药学上可接受的盐,其可用于抑制蛋白法呢基转移酶和癌基因蛋白Ras的法呢基化或抑制从头角鲨烯生产导致胆固醇生物合成的抑制, 除了可用于这些方法的中间体之外,本发明化合物的制备,药物组合物以及使用这些化合物的方法。
-
公开(公告)号:US5059589A
公开(公告)日:1991-10-22
申请号:US488572
申请日:1990-03-02
IPC分类号: A61K38/55
CPC分类号: A61K38/553
摘要: A method and a composition for treating or reducing and/or controlling intraocular pressure comprising administering an effective amount of a renin inhibiting compound of the formula: ##STR1## wherein A is a substituent; W is CO or CHOH and U is CH.sub.2 or NR.sub.2 wherein R.sub.2 is hydrogen or loweralkyl; with the proviso that when W is CHOH then U is CH.sub.2 ; R.sub.1 is loweralkyl, cycloalkylmethyl, benzyl, (alpha, alpha)-dimethylbenzyl, 4-hydroxybenzyl, 4-methoxybenzyl, halobenzyl, (1-naphthyl)methyl, (2-naphthyl)methyl, 1-bezyloxyethyl, phenethyl, phenoxy, thiophenoxy or anilino; R.sub.3 is loweralkyl, loweralkenyl, ((alkoxy)alkoxy)loweralkyl, (thioalkoxy)alkyl, benzyl or heterocyclic ring substituted methyl; and R.sub.4 is substituted hydroxyalkylamino.
摘要翻译: 一种用于治疗或减少和/或控制眼内压的方法和组合物,包括给予有效量的下式的肾素抑制化合物:其中A是取代基; W是CO或CHOH,U是CH 2或NR 2,其中R 2是氢或低级烷基; 条件是当W是CHOH时,则U是CH 2; R1是低级烷基,环烷基甲基,苄基,(α,α) - 二甲基苄基,4-羟基苄基,4-甲氧基苄基,卤代苄基,(1-萘基)甲基,(2-萘基)甲基,1-甲氧基乙基,苯乙基,苯氧基,硫代苯氧基或 阿尼利诺 R3是低级烷基,低级烯基,((烷氧基)烷氧基)低级烷基,(硫代烷氧基)烷基,苄基或杂环取代的甲基; 并且R 4是取代的羟基烷基氨基。
-
公开(公告)号:US5244910A
公开(公告)日:1993-09-14
申请号:US736364
申请日:1991-07-31
申请人: William R. Baker , Steven A. Boyd , Anthony K. L. Fung , Herman H. Stein , Jon F. Denissen , Charles W. Hutchins
发明人: William R. Baker , Steven A. Boyd , Anthony K. L. Fung , Herman H. Stein , Jon F. Denissen , Charles W. Hutchins
IPC分类号: A61K31/495 , A61K31/535 , A61K38/55 , C07D211/46 , C07D401/12 , C07D405/12 , C07D413/12 , C07D451/06 , C07D451/14
CPC分类号: C07D451/06 , A61K31/495 , A61K31/535 , A61K38/553 , C07D211/46 , C07D401/12 , C07D405/12 , C07D413/10 , C07D451/14
摘要: A renin inhibiting compound of the formula: ##STR1## wherein X is O NH or S and G is a mimic of the Leu-Val cleavage site of angiotensinogen; or a pharmaceutically acceptable salt, ester or prodrug thereof; with the proviso that the compound is not N-(3-(4-Morpholino)propyl)-5(S)-(2(S)-(1(S)-(4-(methoxymethoxy)piperidin-1-yl)carbonyl-2- phenyl)ethoxyhexanamido)-6-cyclohexyl-4(S)-hydroxy-2(S)-isopropylhexanamide.
摘要翻译: 下式的肾素抑制化合物:其中X是O NH或S,G是血管紧张素原的Leu-Val切割位点的模拟物; 或其药学上可接受的盐,酯或前药; 条件是该化合物不是N-(3-(4-吗啉代)丙基)-5(S) - (2(S) - (1(S) - (4-(甲氧基甲氧基)哌啶-1-基 )羰基-2-苯基)乙氧基己酰氨基)-6-环己基-4(S) - 羟基-2(S) - 异丙基己酰胺。
-
公开(公告)号:US4167565A
公开(公告)日:1979-09-11
申请号:US739684
申请日:1976-11-08
CPC分类号: C07H19/16
摘要: A method of controlling undesired animals including rodents, coyotes and birds which comprises making available to said animals an edible composition containing, as the active ingredient, a lethal dose of a compound represented by formula ##STR1## wherein R is H, loweralkyl or acetyl; R.sub.1 is H or acetyl; R.sub.2 is H, Cl or NH.sub.2 ; R.sub.3 is H, loweralkyl, alkoxy, cycloalkyl or hydroxyalkyl; R.sub.4 and R.sub.5 are each H, acetyl or propionyl, or when taken together form a p-chlorobenzylidene, a carbonate or an ethoxymethylene moiety; in a suitable carrier.
摘要翻译: 一种控制不需要的动物(包括啮齿动物,土拨鼠和鸟类)的方法,其包括向所述动物提供可食用组合物,所述可食用组合物含有作为活性成分的致死剂量的由式(1)+ tr
2)其中R为H,低级烷基或乙酰基; R1是H或乙酰基; R2是H,Cl或NH2; R3是H,低级烷基,烷氧基,环烷基或羟烷基; R 4和R 5各自为H,乙酰基或丙酰基,或者当一起形成对氯亚苄基,碳酸酯或乙氧基亚甲基部分时; 在合适的载体中。 -
公开(公告)号:US5346887A
公开(公告)日:1994-09-13
申请号:US690148
申请日:1991-04-23
IPC分类号: A61K38/55 , A61K37/00 , A61K31/415 , A61K31/535 , A61K31/56
CPC分类号: A61K38/553 , Y10S514/913
摘要: A method and a composition for treating or reducing and/or controlling intraocular pressure comprising administering an effective amount of a renin inhibiting compound of the formula: ##STR1## wherein A is a substituent; W is CO or CHOH and U is CH.sub.2 or NR.sub.2 wherein R.sub.2 is hydrogen or loweralkyl; with the proviso that when W is CHOH then U is CH.sub.2 ; R.sub.1 is loweralkyl, cycloalkylmethyl, benzyl, (alpha, alpha) -dimethylbenzyl, 4-hydroxybenzyl, 4-methoxybenzyl, halobenzyl, (1-naphthyl)methyl, (2-naphthyl)methyl, 1-benzyloxyethyl, phenethyl, phenoxy, thiophenoxy or anilino; R.sub.3 is loweralkyl, loweralkenyl, ((alkoxy)alkoxy)loweralkyl, (thioalkoxy)alkyl, benzyl or heterocyclic ring substituted methyl; and R.sub.4 is substituted hydroxyalkylamino.
摘要翻译: 一种用于治疗或减少和/或控制眼内压的方法和组合物,包括给予有效量的下式的肾素抑制化合物:其中A是取代基; W是CO或CHOH,U是CH 2或NR 2,其中R 2是氢或低级烷基; 条件是当W是CHOH时,则U是CH 2; R 1是低级烷基,环烷基甲基,苄基,(α,α) - 二甲基苄基,4-羟基苄基,4-甲氧基苄基,卤代苄基,(1-萘基)甲基,(2-萘基)甲基,1-苄氧基乙基,苯乙基,苯氧基, 阿尼利诺 R3是低级烷基,低级烯基,((烷氧基)烷氧基)低级烷基,(硫代烷氧基)烷基,苄基或杂环取代的甲基; 并且R 4是取代的羟基烷基氨基。
-
公开(公告)号:US5036051A
公开(公告)日:1991-07-30
申请号:US488810
申请日:1990-03-02
申请人: Herman H. Stein , Jacob J. Plattner
发明人: Herman H. Stein , Jacob J. Plattner
IPC分类号: A61K38/55
CPC分类号: A61K38/553 , Y10S514/913
摘要: A method and a composition for treating or reducing and/or controlling intraocular pressure comprising administering an effective amount of a renin inhibiting compound of the formula: ##STR1## where A is a substituent; W is CO or CHOH and U is CH.sub.2 or NR.sub.2 wherein R.sub.2 is hydrogen or loweralkyl; with the proviso that when W is CHOH then U is Ch.sub.2 ; R.sub.1 is loweralkyl, cycloalkyl methyl, benzyl, (alpha, alpha)-dimethylbenzyl, 4-hydroxybenzyl, 4-methoxybenzyl, halobenzyl, (1-naphthyl)methyl, (2-naphthyl)methyl, 1-bezyloxyethyl, phenethyl, phenoxy, thiophenoxy or anilino; R.sub.3 is loweralkyl, loweralkenyl, ((alkoxy)alkoxy)loweralkyl, (thioalkoxy)alkyl, benzyl or heterocyclic ring substituted methyl; and R.sub.4 is substituted hydroxyalkyamino.
摘要翻译: 一种用于治疗或减少和/或控制眼内压的方法和组合物,其包括给予有效量的下式的肾素抑制化合物:其中A是取代基; W是CO或CHOH,U是CH 2或NR 2,其中R 2是氢或低级烷基; 条件是当W为CHOH时,则U为Ch2; R1是低级烷基,环烷基甲基,苄基,(α,α) - 二甲基苄基,4-羟基苄基,4-甲氧基苄基,卤代苄基,(1-萘基)甲基,(2-萘基)甲基,1-甲氧基乙基,苯乙基,苯氧基, 或anilino; R3是低级烷基,低级烯基,((烷氧基)烷氧基)低级烷基,(硫代烷氧基)烷基,苄基或杂环取代的甲基; 且R 4为取代的羟基烷基氨基。
-
-
-
-
-
-
-
-
-